CordovaCann (LVRLF) Liabilities and Shareholders Equity (2012 - 2025)

CordovaCann (LVRLF) recorded quarterly Liabilities and Shareholders Equity of $4.6 million in Q2 2025, down 33.81% quarter-over-quarter from $7.0 million in Q2 2024, and down 33.81% on a YoY basis from $7.0 million in Q2 2024.

CordovaCann (LVRLF) Liabilities and Shareholders Equity (2012 - 2025) Analysis & Trends

CordovaCann's Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $4.6 million for Q2 2025.

  • In Q2 2025, Liabilities and Shareholders Equity fell 33.81% year-over-year to $4.6 million; the TTM figure through Jun 2025 stood at $32.4 million (down 22.55% YoY), while the FY2025 annual figure was $4.6 million, down 34.89% from the prior year.
  • Liabilities and Shareholders Equity was $4.6 million for Q2 2025 at CordovaCann, down from $7.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $14.1 million in Q2 2021 to a low of $4.6 million in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $9.3 million across 5 years, with a median of $7.6 million in 2023.
  • The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity soared 32.61% in 2021, then plunged 41.84% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $14.1 million in 2021, then declined by 6.51% to $13.1 million in 2022, then slumped by 41.84% to $7.6 million in 2023, then fell by 8.58% to $7.0 million in 2024, then sank by 33.81% to $4.6 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $4.6 million (Q2 2025), $7.0 million (Q2 2024), and $7.6 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 40.04 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 6.71 Bn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 4.91 Bn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 4.26 Bn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 2.35 Bn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 401.53 Mn
10 CordovaCann - - - 4.62 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 4.62 Mn
Jun 30, 2024 6.98 Mn
Jun 30, 2023 7.64 Mn
Jun 30, 2022 13.14 Mn
Jun 30, 2021 14.05 Mn
Jun 30, 2020 10.60 Mn
Mar 31, 2020 3.72 Mn
Dec 31, 2019 3.45 Mn
Sep 30, 2019 3.51 Mn
Jun 30, 2019 3.47 Mn
Mar 31, 2019 2.55 Mn
Dec 31, 2018 2.59 Mn
Sep 30, 2018 3.02 Mn
Jun 30, 2018 3.78 Mn
Mar 31, 2018 720,888.23
Dec 31, 2017 164,173.47
Sep 30, 2017 2,154.59
Jun 30, 2017 5,024.55
Mar 31, 2017 5,848.85
Dec 31, 2016 8,665.72